Print Friendly Page

Protocol No. NRGBR003

Phase III

Age Group Adult

Sponsor Type National

Title A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or w/o Carboplatin for Node+ or High-Risk Node- Triple-Neg Invasive Breast Cancer

Applicable Disease Sites Breast

Drugs Involved adr (doxorubicin); adria (doxorubicin); adriamycin (doxorubicin); carboplatin; cbdca (carboplatin); cpm (cyclophosphamide); ctx (cyclophosphamide); cyclophosphamide; cytoxan (cyclophosphamide); dox (doxorubicin); doxorubicin; neosar (cyclophosphamide); paclitaxel; paraplatin (carboplatin); taxol (paclitaxel)

Status Open (affiliates only)

Participating Institutions Bellin Memorial Hospital/Cancer Team at Bellin Health; DN Greenwald Center; Mercy Health Systems, Janesville ; Oconomowoc Memorial Hospital, Waukesha Memorial; Waukesha Memorial Hosp